Comparison between Modern Diagnostic IPO and Oremet Alloys IPO.
Modern Diagnostic IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Oremet Alloys IPO is a SME Bookbuilding proposed to list at BSE SME.
| Modern Diagnostic IPO | Oremet Alloys IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Beeline Capital Advisors Pvt.Ltd. | Sobhagya Capital Options Pvt.Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | Maashitla Securities Pvt.Ltd. |
| Market Maker | Spread X Securities Pvt.Ltd. | |
| DRHP | DRHP  | DRHP |
| RHP | ||
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Modern Diagnostic IPO is up to ₹0.00 Cr whereas the issue size of the Oremet Alloys IPO is up to ₹0.00 Cr. The final issue price of Modern Diagnostic IPO is and of Oremet Alloys IPO is .
| Modern Diagnostic IPO | Oremet Alloys IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 41,00,000 shares | 44,26,800 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 41,00,000 shares | 44,26,800 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
Modern Diagnostic IPO opens on , while Oremet Alloys IPO opens on . The closing date of Modern Diagnostic IPO and Oremet Alloys IPO is , and , respectively.
| Modern Diagnostic IPO | Oremet Alloys IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | ||
| Issue Close | ||
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | ||
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Modern Diagnostic IPO P/E ratio is , as compared to Oremet Alloys IPO P/E ratio of .
| Modern Diagnostic IPO | Oremet Alloys IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Modern Diagnostic & Research Centre Limited Financial Information (Restated)
| Oremet Alloys And Castings Limited Financial Information (Restated)Oremet Alloys And Castings Limited's revenue decreased by 22% and profit after tax (PAT) rose by 52% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100.00 | 100 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 65.40% | 69.81% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 25.58% | 61.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.74 | 0.17 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 49.28% | 69.81% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Modern Diagnostic IPO Retail Individual Investors (RII) are offered while in Oremet Alloys IPO retail investors are offered . Qualified Institutional Buyers (QIB) are offered in Modern Diagnostic IPO and in Oremet Alloys IPO.
| Modern Diagnostic IPO | Oremet Alloys IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | ||
| QIB | ||
| NII | ||
| RII | ||
| Employee | ||
| Others | ||
| Total |
Modern Diagnostic IPO subscribed in total, whereas Oremet Alloys IPO subscribed .
| Modern Diagnostic IPO | Oremet Alloys IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
